Respiration Kits
Parallel detection of SARS-CoV-2, Influenza A & B, RSV
Introducing DIANA Biotechnologies
- Founded in 2018 with a private investment of ~ 4M EUR
- Development of DIANA technology –“the Best Czech Innovation in 2017″
- The biggest producer of PCR diagnostics in the Czech Republic
- 100 employees, top scientists & developers (Biology, Chemistry, IT and Automation)
- Global ambitions with globally unique biotech products
Our 4 main business segments
- Development and production of innovative PCR diagnostics (incl. direct PCR technology)
- Ladership in PCR testing of COVID-19 and other respiratory viruses
- In-house bioinformatics, enzyme development, oligo synthesis
- Early drug discovery platform: assay development, HST screening, selectivity profiling, ADME testing
- CRO services for pharma industry
- In-house programs in virology and oncology
- Unique pipeline for development of high-affinity monoclonal antibodies
- Protein, peptide and small molecular targets, both diagnostic and therapeutic applications
- DIANA technology-based methods for ultra-sensitive detection of biomarkers
- Assay development for biotech industry
Integrated manufacturer of high-quality PCR diagnostics
The largest producer of COVID-19 PCR tests in Czechia
Media coverage
